By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research has been awarded C$12.6 million (US$12.7 million) from the provincial government to fund a clinical trials program that will use genomics and personalized medicine in a translational science effort, OICR said Monday.

The funding will be used to support two trials that are part of the High Impact Clinical Trials (HICT) Program over a four-year period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.